KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001691102-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,858
Total Value
$63,157.62
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 3,750 | โ | โ | 231,117 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 22, 2026 | Sale | 2,358 | $26.78 | $63,157.62 | 228,759 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Restricted Stock Unit | Derivative | May 21, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 41,250 | Direct | โ | View Details |